AI‑Driven Drug Discovery Workshop at CSIR‑HRDC, Ghaziabad – Training for Scientists (Apr 7‑9 2026)
From 7‑9 April 2026, CSIR‑HRDC, Ghaziabad hosted a three‑day workshop on AI‑driven drug discovery for CSIR scientists. The programme featured lectures on AI‑based target identification, biomarker discovery, molecular docking and bimolecular simulation, highlighting India’s push to integrate advanced technology into pharmaceutical research.
Overview A three‑day intensive workshop titled “AI‑Driven Drug Discovery: Advanced Tools, Techniques & Applications” was held at the CSIR -Human Resource Development Centre (CSIR‑HRDC), Ghaziabad from 7 to 9 April 2026 . The programme targeted CSIR scientists and technical officers, aiming to impart practical knowledge of cutting‑edge AI tools that are reshaping Drug Discovery . Key Developments Inauguration by Prof. G. N. Sastry (Dept. of Biotechnology, IIT Hyderabad), Dr. T. S. Rana (Head, CSIR‑HRDC) and other dignitaries, highlighting AI’s transformative impact. Lectures by experts from NIPER, IBAB, TCS, CSIR‑NEIST and IITs covering AI‑enabled Target Identification , Biomarker discovery, Molecular Docking & scoring, and Bimolecular Simulation . Hands‑on sessions by Dr. Rajnish Kumar (IIT BHU), Dr. Firoz Khan (CSIR‑CIMAP) and Dr. Tarak Karmakar (IIT Delhi) providing practical exposure to AI‑driven computational pipelines. Certificate distribution and valedictory address by Mrs. Preeti Chaudhary , acknowledging active participation. Important Facts Venue: CSIR‑HRDC, Ghaziabad. Participants: CSIR scientists and technical officers (exact number not disclosed). Organisers: Ministry of Science & Technology, CSIR‑HRDC. Feedback: Highly positive, forming a template for future capacity‑building programmes. UPSC Relevance The workshop underscores the growing convergence of AI with biotechnology, a theme increasingly featured in GS‑3 (Science & Technology) and GS‑4 (Ethics of emerging tech). Understanding AI‑driven drug discovery helps aspirants grasp India’s strategic push for high‑end R&D, public‑private partnerships, and the role of institutions like CSIR in translating research to health outcomes. Way Forward Building on the positive response, the Ministry plans to organize similar workshops across other CSIR labs, incorporate AI modules into regular training curricula, and foster collaborations with industry and academia to accelerate drug pipelines. Aspirants should monitor such initiatives as indicators of India’s innovation ecosystem and potential policy directions in health‑tech and biotech sectors.
Quick Reference
Key Insight
AI‑driven drug discovery workshops signal India's push for high‑end biotech R&D
Key Facts
- The three‑day workshop on AI‑Driven Drug Discovery was held at CSIR‑HRDC, Ghaziabad from 7‑9 April 2026.
- Organised by the Ministry of Science & Technology in collaboration with CSIR‑HRDC and leading academic‑industry partners (IITs, NIPER, TCS, CSIR‑NEIST).
- Target audience: CSIR scientists and technical officers, providing hands‑on training in AI‑enabled target identification, biomarker discovery, molecular docking and bimolecular simulation.
- Key speakers included Prof. G.N. Sastry (IIT Hyderabad), Dr. T.S. Rana (CSIR‑HRDC) and experts from NIPER, IBAB, TCS, CSIR‑NEIST, IIT BHU, IIT Delhi.
- The workshop introduced AI tools such as deep‑learning based virtual screening, generative models for molecule design, and reinforcement‑learning driven docking pipelines.
- Feedback was highly positive and the Ministry plans to replicate the programme across other CSIR labs, integrating AI modules into regular training curricula.
Background
AI is transforming drug discovery by reducing time and cost through in‑silico screening, a priority under India’s ‘Atmanirbhar Bharat’ biotech agenda. CSIR, as the apex R&D body, is spearheading capacity‑building to align public research with industry and global standards, linking GS‑3 themes of emerging technologies and health innovation.
UPSC Syllabus
- Essay — Science, Technology and Society
- GS3 — Developments in science and technology and their applications
- Essay — Education, Knowledge and Culture
- Prelims_GS — Science and Technology Applications
- Essay — Economy, Development and Inequality
- GS3 — IT, Space, Computers, Robotics, Nano-technology, Bio-technology and IPR
Mains Angle
GS‑3: Discuss the strategic importance of AI‑driven drug discovery for India’s health security and biotech ecosystem, and suggest policy measures to foster AI‑biotech integration.